Emergency system to help people stop opioid misuse
Part of Mental health clinical trials.
This Phase 4 study tests an “emergency opioid engagement system” that aims to help people who are opioid-dependent start stopping opioid use. If you’re willing to stop and can safely participate, the program may offer structured support when you’re in the emergency setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have opioid dependence based on DSM-IV-TR criteria, confirmed by study staff/clinician
- Your urine test is positive for opioids
- You are willing to stop using opioids
- You can speak English and can sign informed consent
- You do not have a serious or unstable medical condition that would make the study unsafe
- You are not currently acutely psychotic, severely depressed needing inpatient care, or an immediate suicide risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers an engagement program for young people who tested positive for opioids and meet criteria for opioid dependence. The goal is to help participants stop opioid use safely and learn whether this approach works well in the real-world emergency setting.
This Phase 3 study tests whether starting a high dose of buprenorphine in the emergency department helps people with opioid use disorder come through withdrawal more safely and effectively. It focuses on people whose urine test shows fentanyl and who are already in withdrawal when they arrive.
This study looks at offering buprenorphine through emergency medical services (EMS) to people having an opioid emergency. It aims to see if starting treatment in the field helps people get connected to long-term care.
This study tests a bundled approach to help adults who have had an opioid overdose and are starting buprenorphine in the emergency department continue their recovery after being discharged. It is for people who want to stay on buprenorphine and need support after leaving the hospital.
This study compares a higher dose of buprenorphine (a medicine that helps stop opioid cravings and withdrawal) to the usual dose, given in the emergency department. It aims to see if the higher dose works better to start treatment for opioid use disorder.
This trial tests whether a program that combines medication (buprenorphine) with extra support can help people who have had an opioid overdose avoid future overdoses. If you have been seen at UAB Hospital for an opioid overdose, you may be able to join.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.